Abstract
Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Current Pharmaceutical Design
Title:Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy
Volume: 23 Issue: 40
Author(s): Shubhajit Paul, Paul Wan Sia Heng and Lai Wah Chan*
Affiliation:
- Department of Pharmacy, 18 Science Drive 4, National University of Singapore, 117543,Singapore
Keywords: Photodynamic therapy, photosensitizers, nanocarriers, optimized delivery, carcinoma, cancer.
Abstract: Photodynamic therapy is an evolving treatment modality for cancer owing to its non-invasive approach. This mode of therapy depends on the dynamic interaction of light, oxygen and a photoactive drug to induce oxidative damage to affected cells. This apparently simple technique could be complicated by several factors, mainly contributed by the nature of the physicochemical properties of the photoactive drug, variation in light source and exposure time, as well as tumor physiological environment. This review covers a brief history on the use of various fluorophores in photodynamic therapy, successful marketed formulations and the factors affecting the treatment modalities. The potential of nanostructures as effective delivery carriers with improved photodynamic efficacy is also elaborated. A thorough understanding of the chemistry of photoactive drugs, characteristics of the delivery carriers and light irradiation parameters will enable optimal efficacy of photodynamic therapy.
Export Options
About this article
Cite this article as:
Paul Shubhajit, Heng Wan Sia Paul and Chan Wah Lai *, Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy, Current Pharmaceutical Design 2017; 23 (40) . https://dx.doi.org/10.2174/1381612823666170307104032
DOI https://dx.doi.org/10.2174/1381612823666170307104032 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases
Current Signal Transduction Therapy Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention
Current Medicinal Chemistry Can Diabetes Heal?- From Observations to Perspectives
Current Diabetes Reviews Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
Current Drug Targets The Role of Aromatase Enzyme in Hormone Related Diseases and Plant- Based Aromatase Inhibitors as Therapeutic Regimens
Current Topics in Medicinal Chemistry The Potential of Graphene Oxide and Reduced Graphene Oxide in Diagnosis and Treatment of Cancer
Current Medicinal Chemistry Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application
Current Pharmaceutical Design An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Current Cancer Drug Targets CB1 Cannabinoid Receptors and their Associated Proteins
Current Medicinal Chemistry Telomerase-based Cancer Therapeutics: A Review on their Clinical Trials
Current Topics in Medicinal Chemistry Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME
Anti-Cancer Agents in Medicinal Chemistry Antiproliferative and Proapoptotic Effects of Proteasome Inhibitors and their Combination with Histone Deacetylase Inhibitors on Leukemia Cells
Cardiovascular & Hematological Disorders-Drug Targets Adalimumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
Current Pharmaceutical Design Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology The Structure-property Relationships of GPCR-targeted Drugs Approved between 2011 and 2021
Current Medicinal Chemistry The Potential Role of Claudins in Regulation of Metastasis and Development of Drug Resistance in Breast Cancer
Clinical Cancer Drugs